Long-term Qipian® administration confers resistance to airway inflammation in OVA-induced asthmatic mice
{{output}}
Background: Qipian® is an immunomodulatory agent with established short-term benefits in allergic asthma, but its long-term effects remain unclear. This study aimed to investigate its potential to attenuate the development of as... ...
